447 related articles for article (PubMed ID: 29255415)
1. Adenosine Receptors As Drug Targets for Treatment of Pulmonary Arterial Hypertension.
Alencar AKN; Montes GC; Barreiro EJ; Sudo RT; Zapata-Sudo G
Front Pharmacol; 2017; 8():858. PubMed ID: 29255415
[TBL] [Abstract][Full Text] [Related]
2. Treatment for pulmonary arterial hypertension-associated right ventricular dysfunction.
Gomez-Arroyo J; Sandoval J; Simon MA; Dominguez-Cano E; Voelkel NF; Bogaard HJ
Ann Am Thorac Soc; 2014 Sep; 11(7):1101-15. PubMed ID: 25079379
[TBL] [Abstract][Full Text] [Related]
3. NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension.
Dumas SJ; Bru-Mercier G; Courboulin A; Quatredeniers M; Rücker-Martin C; Antigny F; Nakhleh MK; Ranchoux B; Gouadon E; Vinhas MC; Vocelle M; Raymond N; Dorfmüller P; Fadel E; Perros F; Humbert M; Cohen-Kaminsky S
Circulation; 2018 May; 137(22):2371-2389. PubMed ID: 29444988
[TBL] [Abstract][Full Text] [Related]
4. Emerging therapies for right ventricular dysfunction and failure.
Klinke A; Schubert T; Müller M; Legchenko E; Zelt JGE; Shimauchi T; Napp LC; Rothman AMK; Bonnet S; Stewart DJ; Hansmann G; Rudolph V
Cardiovasc Diagn Ther; 2020 Oct; 10(5):1735-1767. PubMed ID: 33224787
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin and prostaglandin receptors: present and future promising therapeutic targets for pulmonary arterial hypertension.
Zeng C; Liu J; Zheng X; Hu X; He Y
Respir Res; 2023 Nov; 24(1):263. PubMed ID: 37915044
[TBL] [Abstract][Full Text] [Related]
6. N-acylhydrazone derivative ameliorates monocrotaline-induced pulmonary hypertension through the modulation of adenosine AA2R activity.
Alencar AK; Pereira SL; da Silva FE; Mendes LV; Cunha Vdo M; Lima LM; Montagnoli TL; Caruso-Neves C; Ferraz EB; Tesch R; Nascimento JH; Sant'anna CM; Fraga CA; Barreiro EJ; Sudo RT; Zapata-Sudo G
Int J Cardiol; 2014 May; 173(2):154-62. PubMed ID: 24630383
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary Arterial Hypertension: Pathophysiology and Treatment.
Lan NSH; Massam BD; Kulkarni SS; Lang CC
Diseases; 2018 May; 6(2):. PubMed ID: 29772649
[TBL] [Abstract][Full Text] [Related]
8. Contribution of Impaired Parasympathetic Activity to Right Ventricular Dysfunction and Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.
da Silva Gonçalves Bós D; Van Der Bruggen CEE; Kurakula K; Sun XQ; Casali KR; Casali AG; Rol N; Szulcek R; Dos Remedios C; Guignabert C; Tu L; Dorfmüller P; Humbert M; Wijnker PJM; Kuster DWD; van der Velden J; Goumans MJ; Bogaard HJ; Vonk-Noordegraaf A; de Man FS; Handoko ML
Circulation; 2018 Feb; 137(9):910-924. PubMed ID: 29167228
[TBL] [Abstract][Full Text] [Related]
9. Targeted therapies in pulmonary arterial hypertension.
Montani D; Chaumais MC; Guignabert C; Günther S; Girerd B; Jaïs X; Algalarrondo V; Price LC; Savale L; Sitbon O; Simonneau G; Humbert M
Pharmacol Ther; 2014 Feb; 141(2):172-91. PubMed ID: 24134901
[TBL] [Abstract][Full Text] [Related]
10. Multicenter Preclinical Validation of BET Inhibition for the Treatment of Pulmonary Arterial Hypertension.
Van der Feen DE; Kurakula K; Tremblay E; Boucherat O; Bossers GPL; Szulcek R; Bourgeois A; Lampron MC; Habbout K; Martineau S; Paulin R; Kulikowski E; Jahagirdar R; Schalij I; Bogaard HJ; Bartelds B; Provencher S; Berger RMF; Bonnet S; Goumans MJ
Am J Respir Crit Care Med; 2019 Oct; 200(7):910-920. PubMed ID: 31042405
[No Abstract] [Full Text] [Related]
11. Treating pulmonary arterial hypertension: current treatments and future prospects.
Raja SG; Raja SM
Ther Adv Chronic Dis; 2011 Nov; 2(6):359-70. PubMed ID: 23251761
[TBL] [Abstract][Full Text] [Related]
12. Reversal of severe angioproliferative pulmonary arterial hypertension and right ventricular hypertrophy by combined phosphodiesterase-5 and endothelin receptor inhibition.
Cavasin MA; Demos-Davies KM; Schuetze KB; Blakeslee WW; Stratton MS; Tuder RM; McKinsey TA
J Transl Med; 2014 Nov; 12():314. PubMed ID: 25425003
[TBL] [Abstract][Full Text] [Related]
13. Baicalin attenuates chronic hypoxia-induced pulmonary hypertension via adenosine A
Huang X; Wu P; Huang F; Xu M; Chen M; Huang K; Li GP; Xu M; Yao D; Wang L
J Biomed Sci; 2017 Aug; 24(1):52. PubMed ID: 28774332
[TBL] [Abstract][Full Text] [Related]
14. The endothelin system in pulmonary arterial hypertension.
Galié N; Manes A; Branzi A
Cardiovasc Res; 2004 Feb; 61(2):227-37. PubMed ID: 14736539
[TBL] [Abstract][Full Text] [Related]
15. The Role of G Protein-Coupled Receptors in the Right Ventricle in Pulmonary Hypertension.
Viswanathan G; Mamazhakypov A; Schermuly RT; Rajagopal S
Front Cardiovasc Med; 2018; 5():179. PubMed ID: 30619886
[TBL] [Abstract][Full Text] [Related]
16. YC-1 attenuates hypoxia-induced pulmonary arterial hypertension in mice.
Huh JW; Kim SY; Lee JH; Lee YS
Pulm Pharmacol Ther; 2011 Dec; 24(6):638-46. PubMed ID: 21963997
[TBL] [Abstract][Full Text] [Related]
17. Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension.
Montani D; Chaumais MC; Savale L; Natali D; Price LC; Jaïs X; Humbert M; Simonneau G; Sitbon O
Adv Ther; 2009 Sep; 26(9):813-25. PubMed ID: 19768639
[TBL] [Abstract][Full Text] [Related]
18. Urocortin-2 improves right ventricular function and attenuates pulmonary arterial hypertension.
Adão R; Mendes-Ferreira P; Santos-Ribeiro D; Maia-Rocha C; Pimentel LD; Monteiro-Pinto C; Mulvaney EP; Reid HM; Kinsella BT; Potus F; Breuils-Bonnet S; Rademaker MT; Provencher S; Bonnet S; Leite-Moreira AF; Brás-Silva C
Cardiovasc Res; 2018 Jul; 114(8):1165-1177. PubMed ID: 29584808
[TBL] [Abstract][Full Text] [Related]
19. Salidroside attenuates chronic hypoxia-induced pulmonary hypertension via adenosine A2a receptor related mitochondria-dependent apoptosis pathway.
Huang X; Zou L; Yu X; Chen M; Guo R; Cai H; Yao D; Xu X; Chen Y; Ding C; Cai X; Wang L
J Mol Cell Cardiol; 2015 May; 82():153-66. PubMed ID: 25772255
[TBL] [Abstract][Full Text] [Related]
20. ADAMTS8 Promotes the Development of Pulmonary Arterial Hypertension and Right Ventricular Failure: A Possible Novel Therapeutic Target.
Omura J; Satoh K; Kikuchi N; Satoh T; Kurosawa R; Nogi M; Ohtsuki T; Al-Mamun ME; Siddique MAH; Yaoita N; Sunamura S; Miyata S; Hoshikawa Y; Okada Y; Shimokawa H
Circ Res; 2019 Oct; 125(10):884-906. PubMed ID: 31556812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
